Who
Tomohiro Higa
SVP, Finance
Company insider
Files Form 4 as: SVP, Finance, Tenaya Therapeutics.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $14K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Mar 2025
- Last trade
- 18 May 2026
- Last filed
- 19 May 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 May 2026filed 19 May 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,1781,485 at $0.7932 | filing |
| 18 May 2026filed 19 May 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,1731,485 at $0.79 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $393611 at $0.6434 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $538836 at $0.6434 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,3002,022 at $0.6431 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $391611 at $0.64 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $535836 at $0.64 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,2942,022 at $0.64 | filing |
| 3 Feb 2026filed 5 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Code A | —29,250 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,500 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,500 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Code A | —29,250 at $0.00 | filing |
| 17 Nov 2025filed 17 Nov 2025 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,8181,367 at $1.33 | filing |
| 18 Aug 2025filed 18 Aug 2025 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $654523 at $1.25 | filing |
| 18 Aug 2025filed 18 Aug 2025 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $896717 at $1.25 | filing |
| 18 Aug 2025filed 18 Aug 2025 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,1531,722 at $1.25 | filing |
| 16 May 2025filed 16 May 2025 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $6121,390 at $0.44 | filing |
| 10 Mar 2025filed 10 Mar 2025 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $5491,017 at $0.54 | filing |
| 10 Mar 2025filed 10 Mar 2025 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $335620 at $0.54 | filing |
| 10 Mar 2025filed 10 Mar 2025 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $456845 at $0.54 | filing |
News
Tenaya Therapeutics (NASDAQ:TNYA) versus Sutro Biopharma (NASDAQ:STRO) Head-To-Head ComparisonTNYA · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Tomohiro Higa; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.